Companies / Sutro Biopharma, Inc. / Activity
Activity — Sutro Biopharma, Inc.
10 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Bvf INC/IL 13F manager | New | Common stock | $31.18M | +1.3M | 1,251,788 7.55% of shares | medium |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | New | Common stock | $19.96M | +801K | 801,144 4.83% of shares | medium |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | New | Common stock | $17.82M | +715K | 715,307 4.31% of shares | medium |
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | Common stock | $17.82M | +715K | 715,307 4.31% of shares | medium |
| Q2 2026 as of | Merck & Co., Inc. 13F manager | New | Common stock | $9.04M | +272K | 272,351 1.64% of shares | medium |
| Q2 2026 as of | Sigma Planning Corp 13F manager | New | Common stock | $1.49M | +45K | 45,020 0.27% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $516.7K | +16K | 15,563 0.09% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $367.9K | +15K | 14,768 0.09% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $218.1K | +7K | 6,569 0.04% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | New | Common stock | $48.7K | +4K | 4,212 0.03% of shares | low |